November 22, 2020
Tag: Immunology Research Program
![Headshot of Jenny Ting.](https://unclineberger.org/wp-content/uploads/sites/867/2020/02/jenny-ting-600x400.jpg)
October 30, 2020
Microbes in the gut could be protective against hazardous radiation exposure
Jenny Ting, PhD, and colleagues published a study showing bacteria mitigated radiation exposure and enhanced the recovery of blood cell production as well as repair of the gastrointestinal tract.
![Barbara Savoldo and Natalie Grover](https://unclineberger.org/wp-content/uploads/sites/867/2020/07/Savoldo-Grover-feature-600x400.jpg)
July 23, 2020
Excellent research results for CAR-T therapy against Hodgkin lymphoma
CAR-T immunotherapy has been used to treat Hodgkin lymphoma with remarkable success for the first time, according to the results of an early phase clinical trial.
![Jared Weiss and Ben Vincent](https://unclineberger.org/wp-content/uploads/sites/867/2020/04/844A2640-Edit-600x400.jpg)
April 15, 2020
Doctors eye personalized, adaptive cancer vaccine
Jared Weiss, MD, and Ben Vincent, MD, are leading an upcoming clinical trial hoping to cure lung and head and neck squamous cell carcinomas with their PANDA-VAC therapy.
March 11, 2020
Triangle Business Journal: UNC researchers highlight breakthrough for Hodgkin’s lymphoma treatment
![](https://unclineberger.org/wp-content/uploads/sites/867/2020/03/Serody_dotti_savoldo_2-600x400.jpg)
March 9, 2020
CAR-T immunotherapy studied at UNC Lineberger receives fast-track designation from FDA
An investigational therapy for Hodgkin lymphoma received a Regenerative Medicine Advanced Therapy designation from the U.S. Food and Drug Administration.
![Yuliya Pylayeva-Gupta and Paul Dayton](https://unclineberger.org/wp-content/uploads/sites/867/2020/03/pg-dayton-2020-600x400.png)
March 6, 2020
Researchers use innovative ideas to help fight pancreatic cancer
Yuliya Pylayeva-Gupta, PhD, and Paul Dayton, PhD, are studying whether they can use tiny, engineered microbubbles and ultrasound imaging to improve the activation of the immune system against pancreatic cancer, one of the deadliest cancers.
![Headshot of Yuliya Pylayeva-Gupta](https://unclineberger.org/wp-content/uploads/sites/867/2019/09/Yuliya-preferred-2018-horizontal-scaled-e1663079034217-600x400.jpg)
February 7, 2020
Researchers find out what’s keeping cancer-killing T-cells away from pancreatic cancer tumors
Researchers led by Yuliya Pylayeva-Gupta, PhD, have identified the culprit that keeps cancer-killing immune cells from reaching pancreatic cancer tumors. Their findings were published in the journal Cancer Immunology Research.
![Gianpietro Dotti and Yang Xu](https://unclineberger.org/wp-content/uploads/sites/867/2020/02/dotti-xu-study-600x400.png)
February 3, 2020
Researchers develop method to engineer immune cells so they grow even in hostile tumors
Tumors can create a hostile environment for cancer-fighting immune cells. In a new study, University of North Carolina Lineberger Comprehensive Cancer Center researchers have developed a method for engineering immune cells to improve their survival and proliferation, even within a hostile tumor. Researchers led by UNC Lineberger’s Gianpietro Dotti, MD, report in the journal Nature …
![Gianpietro Dotti and Peishun Shou](https://unclineberger.org/wp-content/uploads/sites/867/2020/01/dotti-shou-600x400.png)
January 30, 2020
UNC Lineberger discovery would allow researchers to fine-tune activity of cancer-hunting immune cells
A discovery by University of North Carolina Lineberger Comprehensive Cancer Center researchers could allow scientists to fine-tune genetically engineered immune cells to heighten their killing power against tumors or to decrease their activity level in the case of severe side effects. In a study published in Cancer Cell, researchers led by UNC Lineberger’s Gianpietro Dotti, …